[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100243030":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":13,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":47,"collaborators":49,"id":52,"slug":13,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":13,"eligibilityCriteria":56,"healthyVolunteers":53,"sex":57,"minAge":58,"maxAge":13,"enrollmentInfo":59,"targetDuration":13,"studyType":62,"phases":13,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":32,"whyStopped":13,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Albert Einstein College of Medicine","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Biobank","To have specimens available for IRB approved studies","5 years",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"CASE_ONLY","PROSPECTIVE","There has been a marked increase in our knowledge of Blood Disorders in the last decade. Much of this knowledge comes from examining blood specimens from patients and subjecting these samples to red cell, plasma, serum or DNA analyses. The study team proposes to set up a Hematology biobank, which will include patient histories, their medical progress and a linked but de-identified bank of blood samples. This will enable researchers to have a large database, which can be used to learn more about these diseases.\n\nThe Hematology biobank will use whole blood, red blood cells, plasma, serum and\u002For DNA. Whole blood specimens, which by definition include the white cells that contain DNA, will be collected and stored in the biobank repository at the Institute for Clinical and Translational Research (ICTR) for future studies.\n\nBlood samples will be obtained from two sources:\n\n1. Leftover\u002Fdiscarded whole blood samples that were obtained for standard of care.\n2. Blood samples consisting of 1-5 tubes (3-20 ml of whole blood) from patients with written consent. When possible, these samples will be obtained during routine blood draws performed for a typical visit. It may be necessary to ask patients to specifically donate blood for the study.","\\- Adult and pediatric patients 12 years of age and older",[20],{"name":21,"affiliation":5,"role":22},"Henny Billett","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":13,"email":28},"Swati Goel","CONTACT","7189204137","swgoel@montefiore.org",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Montefiore Medical Center","RECRUITING","The Bronx","New York","10467","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-73.86641,40.84985,{"lat":42,"lon":41},[45],{"name":25,"role":26,"phone":46,"phoneExt":13,"email":13},"718-920-4137",{"type":48,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR",[50],{"name":51,"class":6},"New York Blood Center","100243030",false,"NCT02442011","Hematology Biobank: In Vitro Study of Blood Disorders","Inclusion Criteria:\n\n* Above 12 years of age and referred to the Hematology Division at Montefiore-Einstein\n* Under the care of a Montefiore-Einstein hematologist for a hematologic disorder\n\nExclusion Criteria:\n\n\\- Do not meet the Inclusion Criteria listed above","ALL","12 Years",{"count":60,"type":61},2000,"ESTIMATED","OBSERVATIONAL","This is a biorepository of blood specimens from subjects with different Hematological disorders.",[65],"Hematological Disorders",[67],"Hematology Biobank","2026-01-02",{"date":70,"type":71},"2026-01-06","ACTUAL",{"date":73,"type":13},"2014-01",{"date":75,"type":61},"2030-01",{"name":5,"class":6},1]